IDEAYA Biosciences
Michael Kappler, PhD, currently serves as a Steering Committee Member for the Pistoia Alliance, beginning in February 2024, where the focus is on enhancing R&D innovation through collaborative efforts in the life sciences sector. Since January 2020, Michael has held the position of Director and Head of Research Informatics at IDEAYA Biosciences, overseeing R&D solutions that support various scientific departments. As the CEO and Founder of Moonlight Informatics & Computing Knowledge LLC since 2001, Michael developed a three-dimensional molecular fingerprint technology, contributing to advanced drug design methodologies. Michael's previous roles include Senior Principal Scientist at Nurix Therapeutics, Senior Manager at Afton Chemical, and Principal Scientist at Roche Pharmaceuticals, among others, where responsibilities often involved optimizing research workflows and leading cross-functional teams. Michael holds a Ph.D. in Chemistry from the University of California, Santa Cruz, and a Bachelor of Science in Chemistry from Eastern Michigan University.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California